Global Market for Pain Management Drugs and Devices

The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

Pharmaceuticals market for pain management drugs and devices is expected to increase from $77.9 billion in 2023 to $100.6 billion by the end of 2028, with a CAGR of 5.3% during the forecast period of 2023-2028.

Medical devices market for pain management drugs and devices is expected to increase from $6.7 billion in 2023 to $9.2 billion by the end of 2028, with a CAGR of 6.7% during the forecast period of 2023-2028.

##img_0A##

Report Scope:

The current report provides detailed analysis of the market for pain management drugs and devices. It highlights the current and future market potential of pain management drugs and devices and gives a detailed analysis of the market's drivers, restraints and challenges. The report also covers market projections for 2028 and provides market rankings for key market players. It also covers the competitive environment and regulatory landscape, and it details the market share of pain management drugs and devices based on product and application. Based on products, the global pain management drugs and devices market is segmented into pharmaceuticals and medical devices. Based on applications, the market is segmented into post-operative pain, neuropathic pain, cancer pain, migraine/headache, musculoskeletal pain and other applications. The report includes company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments.

The market has been divided by geography into North America, Europe, Asia-Pacific and the Rest of the world. The North American region comprises countries such as the U.S. and Canada; Europe includes countries Germany, U.K., Italy, France and the Rest of Europe; Asia-Pacific includes countries China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021, which serve as the historical years; 2022 is the base year; and forecast data is given for 2028.

Not covered in the report are drugs or devices that relieve pain by treating the specific condition or disorder. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Only those disease-specific treatments that involve a relief of the pain symptoms associated with the respective condition are included.

Here is a comparison of a treatment for a disease (in this case, rheumatoid arthritis) that naturally relieves symptoms vs. a treatment for the relief of the pain associated with the disease -

Enbrel: Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
Celebrex: Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

Report Includes:

44 data tables and 37 additional tables
An overview of the global market for pain management drugs and devices
Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
Assessment of pain, history of pain and pain management, and information on physical pain treatment modalities and psychological pain therapies.
Coverage of emerging technologies in the pain management market, an assessment of technology advances in opioid drugs, as well as in non-narcotic drugs, which has revolutionized pain management by providing practical alternatives to opioids.
Assessment of factors driving the industry's growth, including market opportunities and restraints
Examination of product categories, clinical trials, new regulatory requirements and relevant patents
Coverage of market trends in undertreatment issues, professional issues, managed care pain issues, new therapies, product pipelines, generics, pain research and drug delivery
Company profiles of major players within the industry, including Abbott Laboratories, AbbVie Inc., Assertio Holdings Inc., Grunenthal GmbH, and Johnson & Johnson

Product Code: HLC026G

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Highlights of the Market for Pain Management Drugs and Devices

Chapter 3 Market Overview

History of Pain and Pain Treatment
The Perception of Pain
Types of Pain
Acute Pain
Chronic Pain
Assessment of Pain
Subjective
Objective
How Pain is Diagnosed
How Pain is Treated
Physical Pain Treatment Modalities
Acupuncture/Acupressure
Ice (Cryotherapy)
Joint Mobilization
Manipulation
Massage
Traction
Radiation Therapy
Radio-Frequency Neuroablation and Epiduroscopy
Surgery
Whirlpool Bath (Thermotherapy)
Psychological Pain Therapies
Biofeedback
Hypnosis
Behavior Modification/Operant Conditioning
Relaxation and Stress Management Training
Imagery
Autogenic Training
Psychosocial Interventions
Distraction and Reframing

Chapter 4 Market Dynamics

Overview
Market Drivers
Market Restraints
Market Challenges

Chapter 5 Market Breakdown by Product

Market Overview
Market Share and Forecast
Pharmaceuticals
Narcotic Drugs
Non-narcotic Drugs
Antimigraine Drugs
Anesthesia Drugs
Other Drugs
Pain Management Devices
Neurostimulation Devices
Infusion Pumps
Ablation Devices

Chapter 6 Market Breakdown by Application

Market Overview
Market Share and Forecast
Musculoskeletal Pain
Post-operative Pain
Neuropathic Pain
Cancer Pain
Migraine/Headache
Other Applications
HIV/AIDS
Burn Pain
Dental Pain

Chapter 7 Market Breakdown by Region

Market Overview
Market Share Forecast
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World

Chapter 8 ESG Development

Introduction to ESG
Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective
Key ESG Issues
ESG Ranking
Consumer Attitudes toward ESG in the Market for Pain Management Drugs and Devices
Case Study
Concluding Remarks from BCC

Chapter 9 Emerging Technologies

Overview
Technology Advancements in Opioid Drugs
Technology Advancements in Non-narcotic Drugs
Technology Advancements in Neuromodulation Devices
Technology Advancements in Infusion Pumps
Trends in Pain Management
Pharmacogenomics
AI Pain Management

Chapter 10 Clinical Trials and Patent Analysis

Overview of Clinical Trials
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Clinical Trials Analysis by Region
Overview of Patent Analysis
Patents by Year
Patents by Top-Ranking Applicant
Patents by Top-Ranking Patent Holder
Patents by Jurisdiction

Chapter 11 Competitive Intelligence

Market Analysis
Market for Pain Management Drugs
Market for Pain Management Medical Devices
Funding
Recent Developments by Key Market Players

Chapter 12 Company Profiles

ABBOTT LABORATORIES
ABBVIE INC
ASSERTIO HOLDINGS INC.
ASTRAZENECA PLC
BOSTON SCIENTIFIC CORP.
ELI LILLY & CO.
ENDO INTERNATIONAL PLC
ENOVIS CORP.
GLAXOSMITHKLINE
GRUNENTHAL GMBH
JOHNSON & JOHNSON
MEDTRONIC PLC
NOVARTIS INTERNATIONAL AG
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.

Chapter 13 Appendix: Acronyms

Product Code: HLC026G

List of Tables

Summary Table B : Global Market for Pain Management Drugs and Devices, by Region, Through 2028
Summary Table A : Global Market for Pain Management Drugs and Devices, by Product, Through 2028
Table 1 : Objective Signs of Pain
Table 2 : Prevalence of Chronic Pain in Older Adults by Site
Table 3 : Opioid Lawsuit Settlements
Table 4 : Global Market for Pain Management Drugs and Devices , by Product, Through 2028
Table 5 : FDA Pain Management Drug Approvals, 2020-2023
Table 6 : Pain Management Major Drugs by Company
Table 7 : Emerging Pain Therapeutics
Table 8 : Global Market for Pain Management Pharmaceuticals, by Region, Through 2028
Table 9 : Global Market for Pain Management Pharmaceuticals, by Product, Through 2028
Table 10 : Classification of Narcotic Analgesics Based on Chemical Structure
Table 11 : Most Common Narcotic Analgesics
Table 12 : Approved Labeling Describing Abuse-Deterrent Properties
Table 13 : Global Market for Narcotic Drugs, by Region, Through 2028
Table 14 : Global Market for Non-narcotic Drugs, by Region, Through 2028
Table 15 : Global Market for Antimigraine Drugs, by Region, Through 2028
Table 16 : Most Commonly Used General Anesthetic Agents
Table 17 : Most Commonly Used Topical and Local Anesthetic Agents
Table 18 : Global Market for Anesthesia Drugs, by Region, Through 2028
Table 19 : Global Market for Other Drugs, by Region, Through 2028
Table 20 : Global Market for Pain Management Devices, by Region, Through 2028
Table 21 : Global Market for Pain Management Devices, by Type, Through 2028
Table 22 : Spinal Cord Stimulation Systems By Major Companies
Table 23 : TENS Devices by Major Companies
Table 24 : Global Market for Neurostimulation Devices, by Region, Through 2028
Table 25 : PCA Devices by Companies
Table 26 : Global Market for Infusion Pumps, by Region, Through 2028
Table 27 : Global Market for Ablation Devices, by Region, Through 2028
Table 28 : Global Market for Pain Management Drugs and Devices, by Application, Through 2028
Table 29 : Pharmacological Musculoskeletal Pain Management
Table 30 : Global Market for Musculoskeletal Pain, by Region, Through 2028
Table 31 : Pharmacological Post-operative Pain Management
Table 32 : Cumulative Volumes of Hip and Knee Procedures, 2012-2021
Table 33 : Global Market for Post-operative Pain, by Region, Through 2028
Table 34 : Neuropathic Pain Medication
Table 35 : Global Market for Neuropathic Pain, by Region, Through 2028
Table 36 : Cancer Pain Medication
Table 37 : Global Market for Cancer Pain, by Region, Through 2028
Table 38 : Global Market for Migraine/Headache Pain, by Region, Through 2028
Table 39 : Global Market for Other Pain Applications, by Region, Through 2028
Table 40 : Global Market for Pain Management Drugs and Devices, by Region, Through 2028
Table 41 : ESG Ranking of Major Pharma Players for Pain Therapeutics,2022
Table 42 : ESG Rankings for Major Pain Management Drug and Device Companies, 2023*
Table 43 : ESG: Environmental Overview
Table 44 : ESG: Social Overview
Table 45 : ESG: Governance Overview
Table 46 : Clinical Trials on Pain Management, by Type of Study, September 2023
Table 47 : Clinical Trials on Pain Mangement, by Status, September 2023
Table 48 : Clinical Trials on Pain Mangement, by Phase, September 2023
Table 49 : Clinical Trials on Pain Mangement, by Region, September 2023
Table 50 : Number of Patents by Top-Ranking Applicant, 2018-2022
Table 51 : Number of Patents by Top-Ranking Patent Holder, 2018-2022
Table 52 : Number of Patents, by Jurisdiction, 2018-2022
Table 53 : Global Market Ranking in the Neuromodulation Segment, by Manufacturer, 2022
Table 54 : Global Market Ranking in the Infusion Pumps Segment, by Manufacturer, 2022
Table 55 : Recent Development, 2020-2023
Table 56 : Abbott Laboratories: Financials, 2021 and 2022
Table 57 : Abbott Laboratories: Product Portfolio
Table 58 : Abbott Laboratories.: Key Developments, 2021-2022
Table 59 : AbbVie Inc.: Financials, 2021 and 2022
Table 60 : AbbVie Inc.: Key Developments, 2021 and 2022
Table 61 : Assertio Holdings Inc.: Financials, 2021 and 2022
Table 62 : Boston Scientific Corp.: Financials, 2021 and 2022
Table 63 : Boston Scientific Corp.: Product Portfolio
Table 64 : Eli Lily & Co.: Financials, 2021 and 2022
Table 65 : Eli Lily & Co.: Key Developments, 2021-2023
Table 66 : Endo International plc: Financials, 2021 and 2022
Table 67 : Endo International plc: Key Developments, 2021-2023
Table 68 : Enovis Corp.: Financials, 2021 and 2022
Table 69 : GlaxoSmithKline: Financials, 2021 and 2022
Table 70 : Grunenthal GmbH: Financials, 2021 and 2022
Table 71 : Grunenthal GmbH: Key Developments, 2022
Table 72 : Johnson & Johnson: Financials, 2021 and 2022
Table 73 : Medtronic plc: Financials, 2021 and 2022
Table 74 : Medtronic plc: Product Portfolio
Table 75 : Medtronic plc: Key Developments, 2020-2023
Table 76 : Novartis International AG: Financials, 2021 and 2022
Table 77 : Vertex Pharmaceuticals Inc.: Key Developments, 2023
Table 78 : Viatris Inc.: Financials, 2021 and 2022
Table 79 : Acronyms Used in This Report

List of Figures

Summary Figure A : Global Market for Pain Management Drugs and Devices, by Product, 2020-2028
Summary Figure B : Global Market for Pain Management Drugs and Devices, by Region, 2020-2028
Figure 1 : Pain Management Techniques
Figure 2 : Pain Management Drugs and Devices: Market Dynamics
Figure 3 : Common Chronic Pain: Reasons
Figure 4 : Cancer Incidence, by Region, 2020 vs. 2040
Figure 5 : Percentage of Global Population above 65 Years, 2018-2022
Figure 6 : Global Market Shares of Pain Management Drugs and Devices , by Product, 2022
Figure 7 : Global Market Shares of Pain Management Pharmaceuticals, by Product, 2022
Figure 8 : Proportion of the Individual Opioid Consumption in Morphine Milligram Equivalents (MME) by Country Income in 2009 vs. 2019
Figure 9 : Total Number of Opioid Prescriptions Dispensed in the U.S., 2010-2020
Figure 10 : Opioid Dispensing Rate per 100 Persons, U.S, 2010-2020
Figure 11 : Global Market for Narcotic Drugs, by Region, 2020-2028
Figure 12 : Number of Drug Overdose Deaths in the U.S., 2019-2021
Figure 13 : Global Market for Non-narcotic Drugs, by Region, 2020-2028
Figure 14 : Symptomatic Medication by Headache Severity
Figure 15 : Preventive Drugs for Migraines
Figure 16 : Global Market for Antimigraine Drugs, by Region, 2020-2028
Figure 17 : Global Market for Anesthesia Drugs, by Region, 2020-2028
Figure 18 : Global Market for Other Drugs, by Region, 2020-2028
Figure 19 : Global Market Shares of Pain Management Devices, by Type, 2022
Figure 20 : SCS Application for Pain Management
Figure 21 : Global Market for Neurostimulation Devices, by Region, 2020-2028
Figure 22 : Global Market for Infusion Pumps, by Region, 2020-2028
Figure 23 : Global Market for Ablation Devices, by Region, 2020-2028
Figure 24 : Global Market Shares of Pain Management Drugs and Devices, by Application, 2022
Figure 25 : Global Market for Musculoskeletal Pain, by Region, 2020-2028
Figure 26 : Global Market for Post-operative Pain, by Region, 2020-2028
Figure 27 : Classification of Neuropathic Pain
Figure 28 : Global Market for Neuropathic Pain, by Region, 2020-2028
Figure 29 : Causes of Cancer Pain
Figure 30 : Global Market for Cancer Pain, by Region, 2020-2028
Figure 31 : Global Market for Migraine/Headache Pain, by Region, 2020-2028
Figure 32 : Burn Pain Management Approach
Figure 33 : Burn Pain Management Approach
Figure 34 : Global Market Shares of Pain Management Drugs and Devices, by Region, 2022
Figure 35 : North American Market for Pain Management, 2020-2028
Figure 36 : European Market for Pain Management, 2020-2028
Figure 37 : Asia-Pacific Market for Pain Management, 2020-2028
Figure 38 : Rest of the World Market for Pain Management, 2020-2028
Figure 39 : ESG Pillars
Figure 40 : Advantages of ESG for Companies
Figure 41 : ESG-Adoption Level across Industries
Figure 42 : Hospitals: Sustainability Priorities
Figure 43 : Novartis: ESG Rating
Figure 44 : Novartis: Major ESG Activities, 2022
Figure 45 : Number of Patents Granted, by Year, 2018-2022
Figure 46 : Abbott Laboratories: Financials, 2021 and 2022
Figure 47 : Abbott Laboratories: Revenue Shares, by Business Unit, 2022
Figure 48 : Abbott Laboratories: Revenue Shares, by Region, 2022
Figure 49 : AbbVie Inc.: Financials, 2021 and 2022
Figure 50 : AbbVie Inc.: Revenue Shares, by Business Unit, 2022
Figure 51 : AbbVie Inc.: Revenue Shares, by Region, 2022
Figure 52 : Assertio Holdings Inc.: Financials, 2021 and 2022
Figure 53 : Assertio Holdings Inc.: Revenue Shares, by Business Unit, 2022
Figure 54 : Boston Scientific Corp.: Financial, 2021 and 2022
Figure 55 : Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 56 : Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
Figure 57 : Eli Lily & Co.: Annual Revenue, 2021 and 2022
Figure 58 : Eli Lily & Co.: Revenue Shares, by Business Unit, 2022
Figure 59 : Eli Lily & Co.: Revenue Shares, by Region, 2022
Figure 60 : Endo International plc: Financials, 2021 and 2022
Figure 61 : Endo International plc: Revenue Shares, by Business Unit, 2022
Figure 62 : Enovis Corp.: Financials, 2021 and 2022
Figure 63 : Enovis Corp.: Revenue Shares, by Business Unit, 2022
Figure 64 : Enovis Corp.: Revenue Shares, by Country/Region, 2022
Figure 65 : GlaxoSmithKline: Financial, 2021 and 2022
Figure 66 : GlaxoSmithKline: Revenue Shares, by Business Unit, 2022
Figure 67 : GlaxoSmithKline: Revenue Shares, by Region, 2022
Figure 68 : Grunenthal GmbH: Financials, 2021 and 2022
Figure 69 : Grunenthal GmbH: Market Share, by Business Segment, 2022
Figure 70 : Grunenthal GmbH: Market Share, by Region, 2022
Figure 71 : Johnson & Johnson: Financials, 2021 and 2022
Figure 72 : Johnson & Johnson: Revenue Shares, by Business Segment, 2022
Figure 73 : Johnson & Johnson: Revenue Shares, by Country/Region, 2022
Figure 74 : Medtronic plc: Financials, 2021 and 2022
Figure 75 : Medtronic plc: Market Share, by Business Unit, 2022
Figure 76 : Medtronic plc: Market Share, by Region, 2022
Figure 77 : Novartis International AG: Financials, 2021 and 2022
Figure 78 : Novartis International AG: Revenue Shares, by Business Unit, 2022
Figure 79 : Novartis AG: Revenue Shares, by Region, 2022
Figure 80 : Viatris Inc.: Financials, 2021 and 2022
Figure 81 : Viatris Inc.: Revenue Shares, by Region, 2022

Global Market for Pain Management Drugs and Devices

Description

Table of Contents

List of Tables

Highlights:

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Market Breakdown by Product

Chapter 6 Market Breakdown by Application

Chapter 7 Market Breakdown by Region

Chapter 8 ESG Development

Chapter 9 Emerging Technologies

Chapter 10 Clinical Trials and Patent Analysis

Chapter 11 Competitive Intelligence

Chapter 12 Company Profiles

Chapter 13 Appendix: Acronyms

List of Tables

List of Figures